Currencies / JAZZ
JAZZ: Jazz Pharmaceuticals plc
111.42
USD
1.20
(1.09%)
JAZZ exchange rate has changed by 1.09% for today. During the day, the instrument was traded at a low of 110.22 and at a high of 112.09.
Follow Jazz Pharmaceuticals plc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- H1
- H4
- D1
- W1
- MN
JAZZ News
- Investor's Business Daily Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity
- Investing Jazz Pharmaceuticals names Renee Gala as next CEO
- TipRanks 3 Must-Watch Stocks with a ‘Perfect 10’ Smart Score - TipRanks.com
- Investing Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating
- Seeking Alpha Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor (NASDAQ:JAZZ)
- Investing PharmaMar FY 2024 slides: Revenue up 11%, net profit soars amid clinical advances
- Investing Zymeworks stock holds steady as H.C. Wainwright reiterates Neutral rating
- Benzinga Avadel Shareholder Seeks Board Shakeup, Citing Millions Lost On Lumryz - Avadel Pharmaceuticals (NASDAQ:AVDL)
- Investing European Commission approves Jazz Pharmaceuticals’ Ziihera for rare cancer
- Investing Avadel stock rises after appeals court upholds LUMRYZ approval
- Seeking Alpha STOK: Impressive Pipeline And Big Backers (NASDAQ:STOK)
- Seeking Alpha Amgen Stock: Imdelltra Data And Q1 Results Impress (NASDAQ:AMGN)
- Investing FDA grants priority review to Zepzelca combo for ES-SCLC
- Investing Jazz Pharmaceuticals Presents Late-Breaking Phase 4 Data Showcasing Xywav ® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Outcomes in Narcolepsy at SLEEP 2025
- Seeking Alpha ASCO 2025: Profiling The Biggest Presentations At The Biggest Cancer Meeting
- Seeking Alpha Harmony Biosciences: If It Ain't Broke (NASDAQ:HRMY)
- Benzinga Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study - Jazz Pharmaceuticals (NASDAQ:JAZZ)
- Investing UBS maintains buy rating on Jazz Pharmaceuticals stock after positive trial data
- Investing Stifel reiterates buy rating for Zymeworks stock after ASCO meeting
- Investing Zepzelca combo extends survival in lung cancer study
- Investing Jazz Pharmaceuticals reports promising Phase 2 trial results for Ziihera
- Seeking Alpha Carillon Chartwell Short Duration High Yield Fund Q1 2025 Commentary
- Investing Jazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav ® (calcium, magnesium, potassium, and sodium oxybates) in Sleep Conditions and Associated Com
- Investing Citizens JMP highlights bispecific antibodies progress
Daily Range
110.22
112.09
Year Range
95.49
148.06
- Previous Close
- 110.27
- Open
- 110.22
- Bid
- 111.42
- Ask
- 111.72
- Low
- 110.22
- High
- 112.09
- Volume
- 250
- Daily Change
- 1.09%
- Month Change
- 5.70%
- 6 Months Change
- -8.90%
- Year Change
- -1.35%
14 July, Monday
15:30
USD
- Act
- 4.245%
- Fcst
- Prev
- 4.255%
15:30
USD
- Act
- 4.125%
- Fcst
- Prev
- 4.145%